Page last updated: 2024-08-17

cordycepin and Esophageal Neoplasms

cordycepin has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, DL; Gao, Y; He, MF; Huang, S; Liao, XZ; Zhang, JX; Zheng, ZS; Zhou, M	1

Other Studies

1 other study(ies) available for cordycepin and Esophageal Neoplasms

Article	Year
Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell death & disease, 2020, 10-16, Volume: 11, Issue:10 Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxyadenosines; Drug Resistance, Neoplasm; Esophageal Neoplasms; Proto-Oncogene Proteins c-akt	2020

Article

Year

Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.

Cell death & disease, 2020, 10-16, Volume: 11, Issue:10

Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxyadenosines; Drug Resistance, Neoplasm; Esophageal Neoplasms; Proto-Oncogene Proteins c-akt

2020